CA2116800A1 - Agent for preventing adhesion of thallium 201 to container - Google Patents

Agent for preventing adhesion of thallium 201 to container

Info

Publication number
CA2116800A1
CA2116800A1 CA002116800A CA2116800A CA2116800A1 CA 2116800 A1 CA2116800 A1 CA 2116800A1 CA 002116800 A CA002116800 A CA 002116800A CA 2116800 A CA2116800 A CA 2116800A CA 2116800 A1 CA2116800 A1 CA 2116800A1
Authority
CA
Canada
Prior art keywords
thallium
container
agent
preventing adhesion
adhesion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002116800A
Other languages
French (fr)
Other versions
CA2116800C (en
Inventor
Makoto Fukushima
Kazuhiro Kimura
Hirohiko Yamauchi
Kenichi Morishita
Keietsu Takahashi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nihon Medi Physics Co Ltd
Original Assignee
Nihon Medi Physics Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nihon Medi Physics Co Ltd filed Critical Nihon Medi Physics Co Ltd
Publication of CA2116800A1 publication Critical patent/CA2116800A1/en
Application granted granted Critical
Publication of CA2116800C publication Critical patent/CA2116800C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1282—Devices used in vivo and carrying the radioactive therapeutic or diagnostic agent, therapeutic or in vivo diagnostic kits, stents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo

Abstract

The present invention is directed to an agent for preventing the adhesion of thallium 201 to a container, said agent comprises a reducing substance as an active ingredient.
The invention is also directed to a radioactive diagnostic agent wherein the adhesion of thallium 201 to a container is prevented. The radioactive diagnostic agent comprises thallium 201 and a reducing substance.
CA002116800A 1993-03-05 1994-03-02 Agent for preventing adhesion of thallium 201 to container Expired - Fee Related CA2116800C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP045104/1993 1993-03-05
JP5045104A JP3051591B2 (en) 1993-03-05 1993-03-05 Anti-adhesion agent for thallium-201 container

Publications (2)

Publication Number Publication Date
CA2116800A1 true CA2116800A1 (en) 1994-09-06
CA2116800C CA2116800C (en) 2001-10-02

Family

ID=12709984

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002116800A Expired - Fee Related CA2116800C (en) 1993-03-05 1994-03-02 Agent for preventing adhesion of thallium 201 to container

Country Status (8)

Country Link
US (1) US5667762A (en)
EP (1) EP0614667B1 (en)
JP (1) JP3051591B2 (en)
KR (2) KR100317874B1 (en)
AT (1) ATE206623T1 (en)
AU (1) AU666420B2 (en)
CA (1) CA2116800C (en)
DE (1) DE69428554T2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2426587A1 (en) * 2000-10-24 2002-08-08 Diatide, Inc. Stabilization of radiopharmaceutical compositions using hydrophilic thioethers and hydrophilic 6-hydroxy chromans
US8412010B2 (en) 2007-09-10 2013-04-02 Banyan Energy, Inc. Compact optics for concentration and illumination systems
US7672549B2 (en) * 2007-09-10 2010-03-02 Banyan Energy, Inc. Solar energy concentrator
US7664350B2 (en) * 2007-09-10 2010-02-16 Banyan Energy, Inc. Compact optics for concentration, aggregation and illumination of light energy
US8705914B2 (en) 2007-09-10 2014-04-22 Banyan Energy, Inc. Redirecting optics for concentration and illumination systems
JP4717924B2 (en) * 2008-12-26 2011-07-06 日本メジフィジックス株式会社 Method for preventing loss of active ingredient of radiopharmaceutical in prefilled syringe

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56125317A (en) * 1980-03-08 1981-10-01 Nippon Mejifuijitsukusu Kk Stable radioactive diagnosticum with radioactive metallic mark
US4510125A (en) * 1982-12-08 1985-04-09 Mallinckrodt, Inc. Process for making lyophilized radiographic imaging kit
JPS59199636A (en) * 1983-04-26 1984-11-12 Nippon Mejifuijitsukusu Kk Radioactive diagnostic agent and production thereof
JPH01197445A (en) * 1988-01-29 1989-08-09 Nippon Mejifuijitsukusu Kk Diagnosticum for mammary cancer

Also Published As

Publication number Publication date
ATE206623T1 (en) 2001-10-15
US5667762A (en) 1997-09-16
KR100429498B1 (en) 2004-05-04
KR100317874B1 (en) 2002-04-06
DE69428554T2 (en) 2002-05-29
DE69428554D1 (en) 2001-11-15
JPH06256223A (en) 1994-09-13
AU5642794A (en) 1994-09-08
KR940021076A (en) 1994-10-17
EP0614667B1 (en) 2001-10-10
AU666420B2 (en) 1996-02-08
JP3051591B2 (en) 2000-06-12
CA2116800C (en) 2001-10-02
EP0614667A1 (en) 1994-09-14

Similar Documents

Publication Publication Date Title
AU6884494A (en) Benzo-fused heterocyclic compounds having a 5-membered ring,processes for their preparation, their use as medicaments, their use as diagnostic agents and medicaments containing them
CA2163003A1 (en) Solubilizer and external preparations containing the same
CA2142126A1 (en) Inhalation powder containing antistatic agent
HUP9901215A3 (en) Microemulsions for use as vehicles for administration of active compounds
CA2168249A1 (en) Psoriasis treatment
EP0671911A4 (en) Carboxy-peptidyl derivatives as antidegenerative active agents.
EG20417A (en) Dihalopropene compounds insecticide acaricide containing same as active ingredient
AU626975B2 (en) Coated granules containing liquid and solid active compounds
EG20222A (en) An oxazoline compound its production and insecticides and/or acoricides containing the same as an active ingredient
CA2116800A1 (en) Agent for preventing adhesion of thallium 201 to container
AU4702093A (en) More easily biologically absorbed tablet containing dichloromethylene diphosphonic acid as the active agent
AU4563093A (en) Echographic contrast agent composition
AU4740093A (en) Use of thiadiazole compounds as an antifouling active ingredient
AU662651B2 (en) Sulfamoyltriazole derivative and bactericide containing the same as active ingredient
AU5654994A (en) Use of dinaphthalenes compounds as antiproliferative agents
AU3526193A (en) Dosage aerosols containing the active substance flezelastin and related structures
AU669783B2 (en) Dermatologic preparation composition containing prostacyclinas active ingredient
AU7467994A (en) Novel polysaccharide and radioprotective agent containing the same as active ingredient
AU650817B2 (en) Furobenzopyran derivatives, process for preparation of same and herbicides containing same as active components
EP0583606A3 (en) New hydrazono-5-beta-androstane derivatives active on the cardiovascular system, processes for their preparation and pharmaceutical compositions containing same.
AU4982693A (en) Amide compound and plant disease control agent containing the same as active ingredient
AU4974393A (en) Skin moisturizer compositions containing dimethylsulphydryl group releasing agent
AU4310693A (en) Fungicidally active compounds
AU2576695A (en) Antiviral agent containing benzodithiin derivative as active ingredient
AU7428094A (en) Hydrazone compound and insecticide containing the same as active ingredient

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed